GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
批准号:
6592299
负责人:
CURTIS A MACHIDA
金额:
$11.11万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-01 至 2003-04-30
中文摘要
猿猴D型逆转录病毒是猿猴获得性疾病的原因
亚洲生物医学研究社区中的免疫缺陷综合征
猕猴,并可以作为模型系统来理解
调控细胞趋向性的包膜糖蛋白基因多样性
并在艾滋病发病机制中起病。逆转录病毒经历高频
它们env基因的突变,并受到选择压力的影响
这导致了新的病理优势的出现
变种。我们已经进行了分子克隆和测序
D型猴逆转录病毒(SRV血清组2;D2/RHE/OR)基因组和
从地方性感染恒河猴中发现变异病毒
与典型的血清组2病毒有关。感染性分子基因组
D2/RHE/OR和一个变种D2/RHE/OR/V1已被恢复。
构建了相互嵌合的病毒来分析
病毒基因组决定簇对体外研究的贡献
淋巴样细胞的传染性。这些实验表明
D2/RHE/OR感染T细胞系的能力降低,尤其是
HUT-78和MT-细胞,以及多种病毒基因组决定因素
影响取向。此外,我们还分离出了传染性分子
血清群4(D4/Cyn/CA)和血清群5(D5/RHE/OR)SRV的克隆。
对这些额外的基因组克隆的完整序列分析表明
群4和群5的SRV在基因上是不同的
以前的特征是血清群。在最近的工作中,通过使用
酵母双杂交系统,我们现在正在尝试
分子克隆编码环境相互作用蛋白的基因,
包括潜在的SRV受体和细胞信号分子。这个
对血清组2、4和5的SRV的完整序列分析有
提供了有关该物种遗传多样性的重要信息
猿猴逆转录病毒。这些分子克隆和潜在的
SRV受体和细胞信号分子的鉴定将
为未来的结构提供必要的分子试剂
真功能和细胞/组织趋向性实验。资金来源
RR00163/艾滋病补充项目8出版物Moudgil T,Mchida CA。
酵母双杂交系统鉴定与之相互作用的分子
猿猴逆转录病毒env基因产物。在第十六届年会的节目中
艾滋病非人类灵长类动物模型研讨会(在佐治亚州亚特兰大举行,
1998年10月7日至10日)(摘要78)。
英文摘要
The simian type D retroviruses are the cause of Simian Acquired
Immunodeficiency Syndrome in biomedical research communities in Asian
macaques, and can serve as model systems in understanding the role of
envelope (env) glycoprotein gene diversity in modulating cell tropism
and onset in AIDS pathogenesis. Retroviruses undergo high-frequency
mutations in their env genes and are subjected to selection pressures
that result in the appearance of new pathologically-advantaged
variants. We have molecularly-cloned and sequenced the complete
genomes of a type D simian retrovirus (SRV serogroup 2; D2/RHE/OR) and
variant viruses recovered from rhesus macaques endemically infected
with the prototypical serogroup 2 virus. Infectious molecular genomes
of D2/RHE/OR and one variant, D2/RHE/OR/V1, have been recovered.
Reciprocal chimeric viruses were constructed to analyze the
contributions made by viral genomic determinants to in vitro
infectivity of lymphoid cells. These exp eriments indicate that
D2/RHE/OR has a reduced ability to infect T-cell lines, especially
Hut-78 and MT-cells, and that multiple viral genomic determinants
influence tropism. In addition, we have isolated infectious molecular
clones of serogroup 4 (D4/CYN/CA) and serogroup 5 (D5/RHE/OR) SRVs.
Complete sequence analyses of these additional genomic clones indicate
that serogroups 4 and 5 SRVs are genetically-distinct from all
previously characterized serogroups. In recent work, with the use of
the yeast two hybrid system, we are now attempting to
molecularly-clone the genes encoding env-interactive proteins,
including potential SRV receptor and cell signaling molecules. The
complete sequence analyses of the serogroup 2, 4 and 5 SRVs has
provided important information concerning the genetic diversity of the
simian retroviruses. These molecular clones and the potential
identification of the SRV receptor and cell signaling molecules will
provide the necessary molecular reagents for future struc
ture-function and cell/tissue tropism experiments. FUNDING
RR00163/AIDS Supplement Project 8 PUBLICATIONS Moudgil T, Machida CA.
Yeast two-hybrid system identification of molecules interacting with
simian retroviral env gene products. In Program of the Sixteen Annual
Symposium on Nonhuman Primate Models for AIDS (held in Atlanta, GA,
October 7-10, 1998) (abstract 78).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dominant Mutans Streptococci Genetic Strains in Caries-Active Children
-
批准号:9136362
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2014
-
负责人:CURTIS A MACHIDA
-
依托单位:
Dominant Mutans Streptococci Genetic Strains in Caries-Active Children
-
批准号:8687956
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:CURTIS A MACHIDA
-
依托单位:
bZIP Repression of Adrenergic Receptor RNA in Neurons
-
批准号:6917675
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2005
-
负责人:CURTIS A MACHIDA
-
依托单位:
bZIP Repression of Adrenergic Receptor RNA in Neurons
-
批准号:7027080
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2005
-
负责人:CURTIS A MACHIDA
-
依托单位:
?1 ADRENERGIC RECEPTOR ACTIVATION & EXPRESSION
-
批准号:6592300
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:CURTIS A MACHIDA
-
依托单位:
Adrenergic Receptor Mechanisms in Antidepressant Therapy
-
批准号:6685266
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2002
-
负责人:CURTIS A MACHIDA
-
依托单位:
Adrenergic Receptor Mechanisms in Antidepressant Therapy
-
批准号:6580613
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2002
-
负责人:CURTIS A MACHIDA
-
依托单位:
NUCLEOCYTOPLASM EXPORT OF SIMIAN RETROVIRUS RNA GENET ELEMENT & PROTEIN FAC:AIDS
-
批准号:6592301
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:CURTIS A MACHIDA
-
依托单位:
NUCLEOCYTOPLASM EXPORT OF SIMIAN RETROVIRUS RNA GENET ELEMENT & PROTEIN FAC:AIDS
-
批准号:6453677
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:CURTIS A MACHIDA
-
依托单位:
GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
-
批准号:6453675
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:CURTIS A MACHIDA
-
依托单位:
?1 ADRENERGIC RECEPTOR ACTIVATION & EXPRESSION
-
批准号:6453676
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:CURTIS A MACHIDA
-
依托单位:
NUCLEOCYTOPLASM EXPORT OF SIMIAN RETROVIRUS RNA GENET ELEMENT & PROTEIN FAC:AIDS
-
批准号:6116089
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:CURTIS A MACHIDA
-
依托单位:
?1 ADRENERGIC RECEPTOR ACTIVATION & EXPRESSION
-
批准号:6116088
-
项目类别:
-
资助金额:$8.93万
-
财政年份:1999
-
负责人:CURTIS A MACHIDA
-
依托单位:
GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
-
批准号:6116087
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:CURTIS A MACHIDA
-
依托单位:
SIMIAN RETROVIRUSES--NOVEL GENE DELIVERY VECTORS
-
批准号:2455413
-
项目类别:
-
资助金额:$15.49万
-
财政年份:1998
-
负责人:CURTIS A MACHIDA
-
依托单位:
GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
-
批准号:6277334
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:CURTIS A MACHIDA
-
依托单位:
SIMIAN RETROVIRUSES--NOVEL GENE DELIVERY VECTORS
-
批准号:2882808
-
项目类别:
-
资助金额:$15.46万
-
财政年份:1998
-
负责人:CURTIS A MACHIDA
-
依托单位:
BETA1 ADRENERGIC RECEPTOR ACTIVATION & EXPRESSION
-
批准号:6277323
-
项目类别:
-
资助金额:$7.52万
-
财政年份:1998
-
负责人:CURTIS A MACHIDA
-
依托单位:
SIMIAN D RETROVIRUSES 4 & 5 SEQUENCE ANALYSES & IMPLICATIONS FOR DIVERGENCE
-
批准号:6277347
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:CURTIS A MACHIDA
-
依托单位:
NUCLEOCYTOPLASMIC EXPORT OF SIMIAN RETROVIRUS RNA GENETIC & PROTEIN FACTORS
-
批准号:6277335
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:CURTIS A MACHIDA
-
依托单位:
海外基金